These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 11265647

  • 1. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes.
    Stan AC, Casares S, Brumeanu TD, Klinman DM, Bona CA.
    Eur J Immunol; 2001 Jan; 31(1):301-10. PubMed ID: 11265647
    [Abstract] [Full Text] [Related]

  • 2. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 3. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM, Schooten E, van Den Elsen PJ.
    Hum Immunol; 2004 Apr 15; 65(4):282-90. PubMed ID: 15120183
    [Abstract] [Full Text] [Related]

  • 4. Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms.
    Payette PJ, Weeratna RD, McCluskie MJ, Davis HL.
    Gene Ther; 2001 Sep 15; 8(18):1395-400. PubMed ID: 11571579
    [Abstract] [Full Text] [Related]

  • 5. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism.
    Cho HJ, Takabayashi K, Cheng PM, Nguyen MD, Corr M, Tuck S, Raz E.
    Nat Biotechnol; 2000 May 15; 18(5):509-14. PubMed ID: 10802617
    [Abstract] [Full Text] [Related]

  • 6. Immune selection in murine tumors. Ph.d thesis.
    Svane IM, Engel AM.
    APMIS Suppl; 2003 May 15; (106):1-46. PubMed ID: 12739251
    [Abstract] [Full Text] [Related]

  • 7. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J, Jagemann B, Wiegard C, Lazaro JF, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse AW.
    Hepatology; 2003 May 15; 37(5):1079-85. PubMed ID: 12717388
    [Abstract] [Full Text] [Related]

  • 8. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

  • 9. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB, Sandlie I, Bogen B.
    Mol Ther; 2006 Apr 15; 13(4):776-85. PubMed ID: 16414309
    [Abstract] [Full Text] [Related]

  • 10. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 15; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 11. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.
    Zelenay S, Elías F, Fló J.
    Eur J Immunol; 2003 May 15; 33(5):1382-92. PubMed ID: 12731065
    [Abstract] [Full Text] [Related]

  • 12. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response.
    Toda M, Kasai M, Hosokawa H, Nakano N, Taniguchi Y, Inouye S, Kaminogawa S, Takemori T, Sakaguchi M.
    Eur J Immunol; 2002 Jun 15; 32(6):1631-9. PubMed ID: 12115646
    [Abstract] [Full Text] [Related]

  • 13. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE, Cooper S, Hangoc G, Chang CH.
    Exp Hematol; 2006 Aug 15; 34(8):1078-84. PubMed ID: 16863914
    [Abstract] [Full Text] [Related]

  • 14. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ, Weiner DB.
    J Leukoc Biol; 2000 Dec 15; 68(6):793-806. PubMed ID: 11129646
    [Abstract] [Full Text] [Related]

  • 15. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E.
    Vaccine; 2009 Aug 27; 27(39):5393-401. PubMed ID: 19596415
    [Abstract] [Full Text] [Related]

  • 16. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
    Encke J, zu Putlitz J, Stremmel W, Wands JR.
    Arch Virol; 2003 Mar 27; 148(3):435-48. PubMed ID: 12607097
    [Abstract] [Full Text] [Related]

  • 17. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
    Maletto B, Rópolo A, Morón V, Pistoresi-Palencia MC.
    J Leukoc Biol; 2002 Sep 27; 72(3):447-54. PubMed ID: 12223511
    [Abstract] [Full Text] [Related]

  • 18. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA, Lee JJ, Chrzanowska-Lightowlers ZM, Robinson JH.
    J Leukoc Biol; 2002 Jul 27; 72(1):163-6. PubMed ID: 12101276
    [Abstract] [Full Text] [Related]

  • 19. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
    Isaji K, Kawase A, Matono M, Guan X, Nishikawa M, Takakura Y.
    J Control Release; 2009 May 05; 135(3):227-33. PubMed ID: 19331843
    [Abstract] [Full Text] [Related]

  • 20. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z, Hofgaard PO, Omholt H, Bogen B.
    Scand J Immunol; 2004 May 05; 60(1-2):143-52. PubMed ID: 15238083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.